Novacyt (LON:NCYT) Shares Up 16% – What’s Next?

Novacyt S.A. (LON:NCYT)’s stock price shot up 16% during mid-day trading on Wednesday . The stock traded as high as GBX 58 ($0.74) and last traded at GBX 58 ($0.74). 849,279 shares changed hands during mid-day trading, an increase of 62% from the average session volume of 522,714 shares. The stock had previously closed at GBX 50 ($0.63).

Novacyt Trading Down 0.7 %

The company has a market cap of £39.55 million, a P/E ratio of -110.38 and a beta of -1.86. The stock has a 50-day moving average of GBX 53.11 and a two-hundred day moving average of GBX 58.40. The company has a debt-to-equity ratio of 18.67, a quick ratio of 4.46 and a current ratio of 4.04.

About Novacyt

Novacyt SA, together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments.